Dialysis-Associated Hypertension Treated with Telmisartan – DiaTel: A Pilot, Placebo-Controlled, Cross-Over, Randomized Trial

Treatment of hypertension in hemodialysis (HD) patients is characterised by lack of evidence for both the blood pressure (BP) target goal and the recommended drug class to use. Telmisartan, an Angiotensin receptor blocker (ARB) that is metabolised in the liver and not excreted via HD extracorporeal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Huber, Matthias, Treutler, Till, Martus, Peter, Kurzidim, Antje, Kreutz, Reinhold, Beige, Joachim
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832496/
https://ncbi.nlm.nih.gov/pubmed/24260194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars